Literatur
Bernier J, Domenge C, Ozsahin M et al. (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350(19): 1945–1952
Bier H, Armonat G, Schirrmacher V, Ganzer U (1989) Postoperative active-specific immunotherapy of lymphnode micrometastasis in a guinea pig tumor model. ORL J Otorhinolaryngol Relat Spec 51: 197–205
Gotte K, Usener D, Riedel F, Hormann K, Schadendorf D, Eichmuller S (2002) Tumor-associated antigens as possible targets for immune therapy in head and neck cancer: comparative mRNA analysis of RAGE and GAGE genes. Acta Otolaryngol 122(5): 546–552
Heimdal JH, Aarstad HJ, Klementsen B, Olofsson J (1999) Peripheral blood mononuclear cell (PBMC) responsiveness in patients with head and neck cancer in relation to tumour stage and prognosis. Acta Otolaryngol 119: 281–284
Karcher J, Dyckhoff G, Beckhove P et al. (2004) Antitumor vaccination in patients with head and neck squamous cell carcinomas with autologous virus-modified tumor cells. Cancer Res 64: 8057–8061
Qin H, Valentino J, Manna S et al. (2001) Gene therapy for head and neck cancer using vaccinia virus expressing IL-2 in a murine model, with evidence of immune suppression. Mol Ther 4: 551–558
Schirrmacher V, Ahlert T, Proebstle T et al. (1998) Immunization with virus-modified tumor cells. Semin Oncol 25: 677–696
Thomas GR, Chen Z, Enamorado I, Bancroft C, Van Waes (2000) IL-12- and IL-2-induced tumor regression in a new murine model of oral squamous-cell carcinoma is promoted by expression of the CD80 co-stimulatory molecule and interferon-gamma. Int J Cancer 86: 368–374
Tisch M, Heimlich F, Daniel V, Opelz G, Maier H (1998) Cellular immune defect caused by postsurgical radiation therapy in patients with head and neck cancer. Otolaryngol Head Neck Surg 119: 412–417
Young MR, Lathers DM (1999) Myeloid progenitor cells mediate immune suppression in patients with head and neck cancers. Int J Immunopharmacol 21: 241–252
Interessenkonflikt:
Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dyckhoff, G., Herold-Mende, C. Anti-Tumor-Impfung bei HNO-Tumoren. HNO 53, 209–212 (2005). https://doi.org/10.1007/s00106-005-1226-1
Issue Date:
DOI: https://doi.org/10.1007/s00106-005-1226-1